香港股市 已收市

Alnylam Pharmaceuticals, Inc. (ALNY)

NasdaqGS - NasdaqGS 即時價格。貨幣為 USD。
加入追蹤清單
148.50-3.59 (-2.36%)
收市:04:00PM EDT
147.99 -0.51 (-0.34%)
收市後: 07:35PM EDT
全螢幕
交易股價資料並非來自所有市場
前收市價152.09
開市151.80
買盤148.11 x 100
賣出價148.56 x 100
今日波幅148.28 - 151.80
52 週波幅143.52 - 218.88
成交量409,245
平均成交量856,114
市值18.778B
Beta 值 (5 年,每月)0.40
市盈率 (最近 12 個月)
每股盈利 (最近 12 個月)-3.52
業績公佈日2024年5月02日 - 2024年5月06日
遠期股息及收益率無 (無)
除息日
1 年預測目標價222.68
  • Zacks

    Why Alnylam Pharmaceuticals (ALNY) Stock Might be a Great Pick

    Alnylam Pharmaceuticals (ALNY) has seen solid earnings estimate revision activity over the past month, and belongs to a strong industry as well.

  • Insider Monkey

    30 Biggest Biotechnology Companies in the World

    In this article, we will be taking a look at the 30 biggest biotechnology companies in the world. If you do not want to learn about the global biotech market, head straight to the 5 Biggest Biotechnology Companies in the World. In the ever-evolving landscape of biotechnology, several companies like Novo Nordisk, Regeneron, and United […]

  • Zacks

    Alnylam (ALNY), Roche's Blood Pressure Drug Meets Study Goal

    Data from a mid-stage study shows that Alnylam (ALNY) and Roche-partnered zilebesiran, when added to standard-of-care, lowers blood pressure significantly in adults with mild-to-moderate hypertension.